Giulia Arrivi

Pubblicazioni

Titolo Pubblicato in Anno
P-195 Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study ANNALS OF ONCOLOGY 2023
Necrolytic Migratory Erythema Impact on Prognosis and Diagnosis of Glucagonoma: A Case Report HSOA JOURNAL OF CLINICAL STUDIES & MEDICAL CASE REPORTS 2023
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study CANCER MANAGEMENT AND RESEARCH 2022
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach RADIOLOGY AND ONCOLOGY 2022
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysis JOURNAL OF NEUROENDOCRINOLOGY 2022
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint Inhibitors CURRENT CANCER DRUG TARGETS 2022
398P Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment ANNALS OF ONCOLOGY 2022
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis CANCER MANAGEMENT AND RESEARCH 2022
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients: The new drug-pin® system comprehensive approach PHARMACEUTICALS 2021
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 2020
Evaluation of prognostic factors for survival in transverse colon cancer CANCERS 2020
The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC). ANNALS OF ONCOLOGY 2020
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study INTEGRATIVE CANCER THERAPIES 2019
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient CASE REPORTS IN ONCOLOGICAL MEDICINE 2019
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center JOURNAL OF CLINICAL MEDICINE 2019
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study 2019
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours 2019
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient CASE REPORTS IN ONCOLOGICAL MEDICINE 2019
Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients. RADIOTHERAPY AND ONCOLOGY 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma